Help is Available to Sort Through Needlestick Prevention Products
PLYMOUTH MEETING, PA-ECRI has published Health Devices Needlestick-Prevention Device Selection Guide, a special report designed to help healthcare facilities wade through the multitude of products available to reduce the risk of needlestick injuries. A nonprofit international health service research organization, ECRI supplies information and consulting services to the healthcare community to support safe and cost-effective patient care. Their special report features comparative evaluations for over 45 needlestick-prevention devices in 11 different device categories. Each evaluation includes supplier and cost information, product descriptions, and ECRI testing results. In addition, the report includes regulatory updates, selection and use guidance, and worksheets to help healthcare facilities comply with safer needle regulations.
Available for purchase thru ECRI, the report costs $295 and can be ordered by calling (610) 825-6000, ext. 5888 or by writing ECRI at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.